US Stock MarketDetailed Quotes

GLMD Galmed Pharmaceuticals

Watchlist
  • 2.8000
  • -0.1600-5.41%
Close Nov 21 16:00 ET
4.22MMarket Cap-667P/E (TTM)

Galmed Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
36.99%2.01M
-34.69%1.22M
-30.02%1.4M
-57.55%7.49M
-12.17%2.15M
-72.71%1.47M
-49.84%1.87M
-67.14%2M
-46.32%17.65M
-67.31%2.45M
Selling and administrative expenses
39.58%1.27M
-35.22%688K
-16.65%766K
-15.74%3.92M
-3.83%1.03M
-19.93%912K
-7.65%1.06M
-29.09%919K
-17.75%4.66M
-12.86%1.07M
-General and administrative expense
39.58%1.27M
-35.22%688K
-16.65%766K
-15.74%3.92M
-3.83%1.03M
-19.93%912K
-7.65%1.06M
-29.09%919K
-17.75%4.66M
-12.86%1.07M
Research and development costs
32.73%738K
-33.99%534K
-41.37%635K
-72.54%3.57M
-18.65%1.12M
-86.89%556K
-68.64%809K
-77.42%1.08M
-52.26%13M
-78.00%1.38M
Operating profit
-36.99%-2.01M
34.69%-1.22M
30.02%-1.4M
57.55%-7.49M
12.17%-2.15M
72.71%-1.47M
49.84%-1.87M
67.14%-2M
46.32%-17.65M
67.31%-2.45M
Net non-operating interest income expense
2,040.00%97K
-62.95%103K
-26.74%126K
32.36%364K
-127.00%-81K
-116.67%-5K
7,050.00%278K
437.25%172K
-47.01%275K
106.90%300K
Non-operating interest income
----
-62.95%103K
----
26.26%375K
----
----
--278K
----
-47.15%297K
----
Total other finance cost
-2,040.00%-97K
----
26.74%-126K
-50.00%11K
15,300.00%456K
116.67%5K
----
-437.25%-172K
-48.84%22K
-100.72%-3K
Other net income (expense)
144.08%216K
-366.67%-490K
Gain on sale of security
----
----
----
144.08%216K
----
----
----
----
-366.67%-490K
----
Income before tax
-29.94%-1.91M
29.76%-1.12M
30.33%-1.28M
61.31%-6.91M
23.61%-2.02M
72.47%-1.47M
57.34%-1.59M
70.21%-1.83M
44.97%-17.87M
64.59%-2.64M
Income tax
Net income
-29.94%-1.91M
29.76%-1.12M
30.33%-1.28M
61.31%-6.91M
23.61%-2.02M
72.47%-1.47M
57.34%-1.59M
70.21%-1.83M
44.97%-17.87M
64.59%-2.64M
Net income continuous Operations
-29.94%-1.91M
29.76%-1.12M
30.33%-1.28M
61.31%-6.91M
23.61%-2.02M
72.47%-1.47M
57.34%-1.59M
70.21%-1.83M
44.97%-17.87M
64.59%-2.64M
Minority interest income
Net income attributable to the parent company
-29.94%-1.91M
29.76%-1.12M
30.33%-1.28M
61.31%-6.91M
23.61%-2.02M
72.47%-1.47M
57.34%-1.59M
70.21%-1.83M
44.97%-17.87M
64.59%-2.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-29.94%-1.91M
29.76%-1.12M
30.33%-1.28M
61.31%-6.91M
23.61%-2.02M
72.47%-1.47M
57.34%-1.59M
70.21%-1.83M
44.97%-17.87M
64.59%-2.64M
Basic earnings per share
32.65%-27.72
81.05%-2.16
78.70%-2.76
76.53%-30
73.36%-4.7949
-7.52%-41.16
57.78%-11.4
70.57%-12.96
46.21%-127.8
66.67%-18
Diluted earnings per share
32.65%-27.72
81.05%-2.16
78.70%-2.76
76.53%-30
73.36%-4.7949
-7.52%-41.16
57.78%-11.4
70.57%-12.96
46.21%-127.8
66.67%-18
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 36.99%2.01M-34.69%1.22M-30.02%1.4M-57.55%7.49M-12.17%2.15M-72.71%1.47M-49.84%1.87M-67.14%2M-46.32%17.65M-67.31%2.45M
Selling and administrative expenses 39.58%1.27M-35.22%688K-16.65%766K-15.74%3.92M-3.83%1.03M-19.93%912K-7.65%1.06M-29.09%919K-17.75%4.66M-12.86%1.07M
-General and administrative expense 39.58%1.27M-35.22%688K-16.65%766K-15.74%3.92M-3.83%1.03M-19.93%912K-7.65%1.06M-29.09%919K-17.75%4.66M-12.86%1.07M
Research and development costs 32.73%738K-33.99%534K-41.37%635K-72.54%3.57M-18.65%1.12M-86.89%556K-68.64%809K-77.42%1.08M-52.26%13M-78.00%1.38M
Operating profit -36.99%-2.01M34.69%-1.22M30.02%-1.4M57.55%-7.49M12.17%-2.15M72.71%-1.47M49.84%-1.87M67.14%-2M46.32%-17.65M67.31%-2.45M
Net non-operating interest income expense 2,040.00%97K-62.95%103K-26.74%126K32.36%364K-127.00%-81K-116.67%-5K7,050.00%278K437.25%172K-47.01%275K106.90%300K
Non-operating interest income -----62.95%103K----26.26%375K----------278K-----47.15%297K----
Total other finance cost -2,040.00%-97K----26.74%-126K-50.00%11K15,300.00%456K116.67%5K-----437.25%-172K-48.84%22K-100.72%-3K
Other net income (expense) 144.08%216K-366.67%-490K
Gain on sale of security ------------144.08%216K-----------------366.67%-490K----
Income before tax -29.94%-1.91M29.76%-1.12M30.33%-1.28M61.31%-6.91M23.61%-2.02M72.47%-1.47M57.34%-1.59M70.21%-1.83M44.97%-17.87M64.59%-2.64M
Income tax
Net income -29.94%-1.91M29.76%-1.12M30.33%-1.28M61.31%-6.91M23.61%-2.02M72.47%-1.47M57.34%-1.59M70.21%-1.83M44.97%-17.87M64.59%-2.64M
Net income continuous Operations -29.94%-1.91M29.76%-1.12M30.33%-1.28M61.31%-6.91M23.61%-2.02M72.47%-1.47M57.34%-1.59M70.21%-1.83M44.97%-17.87M64.59%-2.64M
Minority interest income
Net income attributable to the parent company -29.94%-1.91M29.76%-1.12M30.33%-1.28M61.31%-6.91M23.61%-2.02M72.47%-1.47M57.34%-1.59M70.21%-1.83M44.97%-17.87M64.59%-2.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -29.94%-1.91M29.76%-1.12M30.33%-1.28M61.31%-6.91M23.61%-2.02M72.47%-1.47M57.34%-1.59M70.21%-1.83M44.97%-17.87M64.59%-2.64M
Basic earnings per share 32.65%-27.7281.05%-2.1678.70%-2.7676.53%-3073.36%-4.7949-7.52%-41.1657.78%-11.470.57%-12.9646.21%-127.866.67%-18
Diluted earnings per share 32.65%-27.7281.05%-2.1678.70%-2.7676.53%-3073.36%-4.7949-7.52%-41.1657.78%-11.470.57%-12.9646.21%-127.866.67%-18
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data